Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Body Height | 29 | 2012 | 1565 | 2.060 |
Why?
|
Social Class | 35 | 2012 | 2007 | 1.890 |
Why?
|
Birth Weight | 28 | 2011 | 2122 | 1.020 |
Why?
|
Body Mass Index | 52 | 2011 | 13048 | 0.990 |
Why?
|
Coronary Disease | 22 | 2009 | 5914 | 0.890 |
Why?
|
Smoking | 26 | 2011 | 9081 | 0.790 |
Why?
|
Cause of Death | 14 | 2010 | 3717 | 0.770 |
Why?
|
Blood Pressure | 27 | 2012 | 8531 | 0.750 |
Why?
|
Obesity | 32 | 2011 | 13085 | 0.740 |
Why?
|
Epidemiologic Research Design | 3 | 2012 | 368 | 0.740 |
Why?
|
Lactase | 3 | 2010 | 72 | 0.730 |
Why?
|
Mortality | 10 | 2010 | 2909 | 0.710 |
Why?
|
Cardiovascular Diseases | 30 | 2012 | 15645 | 0.690 |
Why?
|
Mendelian Randomization Analysis | 6 | 2012 | 1040 | 0.690 |
Why?
|
Genetic Variation | 17 | 2012 | 6611 | 0.680 |
Why?
|
Breast Feeding | 10 | 2011 | 1362 | 0.670 |
Why?
|
Socioeconomic Factors | 32 | 2012 | 7848 | 0.650 |
Why?
|
Intelligence | 8 | 2011 | 925 | 0.590 |
Why?
|
Income | 8 | 2011 | 1877 | 0.570 |
Why?
|
C-Reactive Protein | 12 | 2012 | 3851 | 0.540 |
Why?
|
Child Development | 9 | 2011 | 2329 | 0.540 |
Why?
|
Educational Status | 13 | 2011 | 2511 | 0.520 |
Why?
|
Polymorphism, Single Nucleotide | 39 | 2012 | 16036 | 0.520 |
Why?
|
Parents | 8 | 2012 | 3594 | 0.520 |
Why?
|
Epidemiology | 2 | 2008 | 278 | 0.510 |
Why?
|
Cohort Studies | 66 | 2012 | 41718 | 0.460 |
Why?
|
Poverty | 7 | 2011 | 2719 | 0.450 |
Why?
|
Genotype | 36 | 2012 | 13035 | 0.450 |
Why?
|
Overnutrition | 3 | 2008 | 25 | 0.440 |
Why?
|
Hypercholesterolemia | 5 | 2011 | 1144 | 0.440 |
Why?
|
Epidemiologic Methods | 7 | 2008 | 1326 | 0.440 |
Why?
|
Body Weight | 14 | 2011 | 4627 | 0.430 |
Why?
|
Risk Factors | 78 | 2012 | 74886 | 0.420 |
Why?
|
Overweight | 7 | 2011 | 2448 | 0.410 |
Why?
|
Scotland | 12 | 2010 | 142 | 0.390 |
Why?
|
Malnutrition | 3 | 2011 | 632 | 0.390 |
Why?
|
Diphtheria Antitoxin | 1 | 2011 | 7 | 0.380 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2011 | 276 | 0.380 |
Why?
|
Diphtheria | 1 | 2011 | 32 | 0.370 |
Why?
|
Lactose Intolerance | 2 | 2008 | 28 | 0.370 |
Why?
|
England | 12 | 2012 | 533 | 0.350 |
Why?
|
Proteins | 9 | 2011 | 6001 | 0.350 |
Why?
|
India | 11 | 2011 | 2334 | 0.350 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2011 | 187 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 28 | 2011 | 18063 | 0.350 |
Why?
|
Lactose | 1 | 2010 | 95 | 0.350 |
Why?
|
Health Surveys | 14 | 2011 | 4056 | 0.340 |
Why?
|
Fibrinogen | 4 | 2006 | 892 | 0.340 |
Why?
|
Genetic Loci | 8 | 2011 | 2629 | 0.340 |
Why?
|
Myocardial Ischemia | 4 | 2009 | 2131 | 0.340 |
Why?
|
Humans | 211 | 2012 | 767040 | 0.330 |
Why?
|
Adiposity | 9 | 2011 | 1894 | 0.330 |
Why?
|
Female | 150 | 2012 | 396660 | 0.330 |
Why?
|
Meta-Analysis as Topic | 14 | 2011 | 1364 | 0.330 |
Why?
|
Polymorphism, Genetic | 12 | 2011 | 4247 | 0.320 |
Why?
|
Body Size | 5 | 2010 | 462 | 0.310 |
Why?
|
Male | 134 | 2012 | 364203 | 0.310 |
Why?
|
Middle Aged | 95 | 2012 | 223233 | 0.310 |
Why?
|
Public Health | 3 | 2011 | 2681 | 0.310 |
Why?
|
Embryonic and Fetal Development | 3 | 2004 | 420 | 0.300 |
Why?
|
Child Nutritional Physiological Phenomena | 3 | 2011 | 294 | 0.300 |
Why?
|
Cholesterol | 7 | 2012 | 2905 | 0.300 |
Why?
|
Child | 71 | 2012 | 80771 | 0.300 |
Why?
|
Child Welfare | 3 | 2007 | 522 | 0.300 |
Why?
|
Adult | 94 | 2012 | 223317 | 0.300 |
Why?
|
Milk | 2 | 2010 | 437 | 0.290 |
Why?
|
Thinness | 3 | 2010 | 482 | 0.290 |
Why?
|
Genome-Wide Association Study | 20 | 2012 | 12790 | 0.290 |
Why?
|
Molecular Epidemiology | 2 | 2008 | 473 | 0.290 |
Why?
|
Alcohol Drinking | 10 | 2010 | 4045 | 0.290 |
Why?
|
Life Style | 9 | 2008 | 3931 | 0.280 |
Why?
|
Health Behavior | 4 | 2010 | 2650 | 0.280 |
Why?
|
Journal Impact Factor | 1 | 2008 | 157 | 0.280 |
Why?
|
Absorptiometry, Photon | 7 | 2010 | 1757 | 0.280 |
Why?
|
Parent-Child Relations | 1 | 2012 | 772 | 0.270 |
Why?
|
Maternal Welfare | 1 | 2007 | 113 | 0.270 |
Why?
|
Body Composition | 7 | 2010 | 2454 | 0.270 |
Why?
|
Mothers | 7 | 2011 | 2209 | 0.270 |
Why?
|
Random Allocation | 2 | 2008 | 2394 | 0.270 |
Why?
|
Sanitation | 1 | 2007 | 83 | 0.270 |
Why?
|
Norway | 5 | 2008 | 500 | 0.270 |
Why?
|
Infant, Newborn | 32 | 2012 | 26396 | 0.260 |
Why?
|
Body Fat Distribution | 2 | 2006 | 246 | 0.260 |
Why?
|
Longitudinal Studies | 24 | 2012 | 14766 | 0.260 |
Why?
|
Hypertension | 13 | 2011 | 8615 | 0.250 |
Why?
|
Heredity | 1 | 2006 | 149 | 0.250 |
Why?
|
Nutritional Status | 4 | 2008 | 1628 | 0.250 |
Why?
|
Blood Glucose | 8 | 2011 | 6421 | 0.250 |
Why?
|
Homocysteine | 2 | 2011 | 637 | 0.240 |
Why?
|
Prenatal Exposure Delayed Effects | 9 | 2010 | 2538 | 0.240 |
Why?
|
Child Behavior | 1 | 2010 | 864 | 0.240 |
Why?
|
Body Constitution | 2 | 2007 | 273 | 0.240 |
Why?
|
Odds Ratio | 14 | 2011 | 9660 | 0.240 |
Why?
|
Forced Expiratory Volume | 7 | 2011 | 1830 | 0.240 |
Why?
|
Housing | 2 | 2007 | 683 | 0.240 |
Why?
|
Cross-Cultural Comparison | 1 | 2008 | 638 | 0.230 |
Why?
|
Aging | 12 | 2010 | 8729 | 0.230 |
Why?
|
Review Literature as Topic | 1 | 2006 | 297 | 0.230 |
Why?
|
Causality | 6 | 2012 | 1253 | 0.220 |
Why?
|
Neural Tube Defects | 1 | 2006 | 255 | 0.220 |
Why?
|
Genome, Human | 7 | 2012 | 4441 | 0.220 |
Why?
|
Health Status | 3 | 2011 | 4091 | 0.220 |
Why?
|
gamma-Glutamyltransferase | 4 | 2008 | 143 | 0.220 |
Why?
|
Child Behavior Disorders | 1 | 2008 | 812 | 0.220 |
Why?
|
Child Nutrition Disorders | 1 | 2005 | 140 | 0.220 |
Why?
|
Aged | 64 | 2012 | 171319 | 0.210 |
Why?
|
Infant | 28 | 2012 | 36485 | 0.210 |
Why?
|
Neoplasms | 13 | 2009 | 22350 | 0.210 |
Why?
|
Leg | 2 | 2011 | 1087 | 0.210 |
Why?
|
Proportional Hazards Models | 16 | 2010 | 12536 | 0.210 |
Why?
|
Stroke | 9 | 2011 | 9746 | 0.210 |
Why?
|
Estrogen Replacement Therapy | 2 | 2006 | 1209 | 0.210 |
Why?
|
Pregnancy | 29 | 2012 | 30238 | 0.210 |
Why?
|
Women's Health | 5 | 2008 | 2082 | 0.210 |
Why?
|
Child, Preschool | 28 | 2012 | 42606 | 0.210 |
Why?
|
Psychophysiologic Disorders | 1 | 2004 | 222 | 0.210 |
Why?
|
Social Justice | 1 | 2007 | 487 | 0.200 |
Why?
|
Data Interpretation, Statistical | 4 | 2011 | 2698 | 0.200 |
Why?
|
Parenting | 1 | 2008 | 708 | 0.200 |
Why?
|
Rural Health | 4 | 2010 | 302 | 0.200 |
Why?
|
Adolescent | 46 | 2012 | 89046 | 0.200 |
Why?
|
Benchmarking | 1 | 2008 | 1056 | 0.200 |
Why?
|
Estrogen Receptor alpha | 1 | 2006 | 581 | 0.190 |
Why?
|
Diabetes Complications | 1 | 2008 | 1319 | 0.190 |
Why?
|
Occupations | 5 | 2005 | 516 | 0.190 |
Why?
|
Quantitative Trait Loci | 6 | 2012 | 2131 | 0.190 |
Why?
|
Cerebral Infarction | 2 | 2003 | 968 | 0.190 |
Why?
|
Alanine Transaminase | 4 | 2008 | 609 | 0.180 |
Why?
|
Fasting | 5 | 2011 | 1607 | 0.180 |
Why?
|
Insulin | 5 | 2008 | 6602 | 0.180 |
Why?
|
Soccer | 1 | 2002 | 142 | 0.180 |
Why?
|
Cluster Analysis | 1 | 2007 | 2721 | 0.180 |
Why?
|
Folic Acid | 4 | 2011 | 1336 | 0.180 |
Why?
|
Tooth, Deciduous | 2 | 2011 | 76 | 0.180 |
Why?
|
Waist-Hip Ratio | 4 | 2011 | 520 | 0.180 |
Why?
|
Confidence Intervals | 7 | 2008 | 2920 | 0.180 |
Why?
|
Hormone Replacement Therapy | 1 | 2006 | 756 | 0.170 |
Why?
|
Obstetrics | 1 | 2007 | 679 | 0.170 |
Why?
|
Cholesterol, HDL | 2 | 2006 | 1816 | 0.170 |
Why?
|
Intermediate Filament Proteins | 3 | 2011 | 261 | 0.170 |
Why?
|
Prospective Studies | 31 | 2011 | 54886 | 0.170 |
Why?
|
Health Status Disparities | 2 | 2010 | 1882 | 0.170 |
Why?
|
Weight Gain | 4 | 2011 | 2360 | 0.170 |
Why?
|
Follow-Up Studies | 24 | 2011 | 39317 | 0.170 |
Why?
|
Apolipoproteins E | 3 | 2011 | 1459 | 0.160 |
Why?
|
Finland | 8 | 2010 | 608 | 0.160 |
Why?
|
Chromosomes, Human, Pair 15 | 2 | 2011 | 361 | 0.160 |
Why?
|
Prevalence | 15 | 2011 | 15851 | 0.160 |
Why?
|
Angina Pectoris | 1 | 2002 | 956 | 0.160 |
Why?
|
Testosterone | 2 | 2010 | 2490 | 0.150 |
Why?
|
Stress, Psychological | 5 | 2012 | 4526 | 0.150 |
Why?
|
Gene Frequency | 6 | 2011 | 3621 | 0.150 |
Why?
|
History, 19th Century | 2 | 2011 | 714 | 0.150 |
Why?
|
Gestational Age | 8 | 2010 | 3618 | 0.150 |
Why?
|
Fetus | 4 | 2010 | 1878 | 0.150 |
Why?
|
Suicide | 1 | 2009 | 1606 | 0.150 |
Why?
|
Risk-Taking | 2 | 2003 | 1023 | 0.140 |
Why?
|
Growth | 3 | 2011 | 366 | 0.140 |
Why?
|
Age Factors | 14 | 2011 | 18401 | 0.140 |
Why?
|
Anthropometry | 6 | 2010 | 1345 | 0.140 |
Why?
|
Menopause | 3 | 2004 | 1655 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2003 | 718 | 0.140 |
Why?
|
Hydrocortisone | 1 | 2005 | 1840 | 0.140 |
Why?
|
Tunica Intima | 4 | 2008 | 455 | 0.140 |
Why?
|
Breast | 2 | 2009 | 1972 | 0.140 |
Why?
|
Intelligence Tests | 4 | 2011 | 504 | 0.130 |
Why?
|
Menarche | 2 | 2010 | 538 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2010 | 12250 | 0.130 |
Why?
|
Patient Admission | 2 | 2005 | 1364 | 0.130 |
Why?
|
Parity | 3 | 2004 | 931 | 0.130 |
Why?
|
Kidney Neoplasms | 2 | 2010 | 4282 | 0.130 |
Why?
|
History, 20th Century | 3 | 2011 | 2765 | 0.130 |
Why?
|
Vital Capacity | 4 | 2011 | 996 | 0.130 |
Why?
|
Brazil | 2 | 2011 | 1250 | 0.130 |
Why?
|
Smoking Cessation | 2 | 2009 | 2085 | 0.130 |
Why?
|
Korea | 4 | 2009 | 97 | 0.120 |
Why?
|
Students | 2 | 2002 | 1744 | 0.120 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3186 | 0.120 |
Why?
|
Tooth Eruption | 2 | 2011 | 29 | 0.120 |
Why?
|
Maternal Age | 2 | 2008 | 804 | 0.120 |
Why?
|
Linear Models | 10 | 2011 | 5875 | 0.120 |
Why?
|
Heart Diseases | 1 | 2007 | 2817 | 0.120 |
Why?
|
Exercise | 8 | 2010 | 5954 | 0.120 |
Why?
|
Receptor, Melanocortin, Type 4 | 3 | 2011 | 131 | 0.120 |
Why?
|
Phenotype | 12 | 2012 | 16718 | 0.110 |
Why?
|
Attitude to Health | 1 | 2003 | 2023 | 0.110 |
Why?
|
Medical Record Linkage | 2 | 2005 | 286 | 0.110 |
Why?
|
Haptoglobins | 2 | 2012 | 165 | 0.110 |
Why?
|
Alleles | 12 | 2012 | 6893 | 0.110 |
Why?
|
Mammography | 1 | 2004 | 2431 | 0.110 |
Why?
|
Nerve Tissue Proteins | 4 | 2011 | 4401 | 0.110 |
Why?
|
Infant, Low Birth Weight | 3 | 2009 | 871 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2008 | 1939 | 0.110 |
Why?
|
Cross-Sectional Studies | 18 | 2012 | 26325 | 0.110 |
Why?
|
Infant Nutritional Physiological Phenomena | 3 | 2005 | 352 | 0.110 |
Why?
|
Milk, Human | 2 | 2010 | 490 | 0.110 |
Why?
|
Sex Factors | 9 | 2011 | 10622 | 0.100 |
Why?
|
Tunica Media | 3 | 2008 | 107 | 0.100 |
Why?
|
Denmark | 3 | 2011 | 776 | 0.100 |
Why?
|
Europe | 5 | 2011 | 3432 | 0.100 |
Why?
|
Risk Assessment | 15 | 2011 | 24299 | 0.100 |
Why?
|
Urban Population | 3 | 2011 | 2044 | 0.100 |
Why?
|
Age Distribution | 5 | 2010 | 2870 | 0.100 |
Why?
|
Insulin Resistance | 5 | 2007 | 3986 | 0.100 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2012 | 40 | 0.100 |
Why?
|
Observation | 2 | 2012 | 310 | 0.100 |
Why?
|
Employment | 3 | 2010 | 1110 | 0.100 |
Why?
|
Occupational Exposure | 1 | 2002 | 1807 | 0.100 |
Why?
|
Fetal Development | 2 | 2008 | 777 | 0.100 |
Why?
|
Coronary Artery Disease | 4 | 2010 | 6573 | 0.100 |
Why?
|
Mental Disorders | 3 | 2012 | 6873 | 0.100 |
Why?
|
Transcription Initiation Site | 1 | 2012 | 190 | 0.100 |
Why?
|
Thrombosis | 1 | 2005 | 2954 | 0.090 |
Why?
|
Body Weights and Measures | 1 | 2012 | 208 | 0.090 |
Why?
|
Paired Box Transcription Factors | 1 | 2012 | 205 | 0.090 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2011 | 3253 | 0.090 |
Why?
|
Calcifediol | 1 | 2012 | 160 | 0.090 |
Why?
|
Adipose Tissue | 8 | 2010 | 3324 | 0.090 |
Why?
|
Famous Persons | 1 | 2012 | 109 | 0.090 |
Why?
|
Registries | 5 | 2009 | 8351 | 0.090 |
Why?
|
Young Adult | 13 | 2011 | 59980 | 0.090 |
Why?
|
Case-Control Studies | 11 | 2011 | 22254 | 0.090 |
Why?
|
Cotinine | 1 | 2011 | 206 | 0.090 |
Why?
|
Facial Bones | 1 | 2012 | 209 | 0.090 |
Why?
|
Risk | 6 | 2011 | 9606 | 0.090 |
Why?
|
Incidence | 10 | 2008 | 21526 | 0.090 |
Why?
|
History, 17th Century | 1 | 2010 | 108 | 0.090 |
Why?
|
Genetics, Population | 3 | 2012 | 943 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 350 | 0.090 |
Why?
|
Logistic Models | 7 | 2008 | 13284 | 0.080 |
Why?
|
Receptors, Nicotinic | 2 | 2011 | 494 | 0.080 |
Why?
|
Respiratory Function Tests | 2 | 2011 | 1695 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3804 | 0.080 |
Why?
|
Blood Pressure Determination | 2 | 2011 | 646 | 0.080 |
Why?
|
Healthy People Programs | 1 | 2009 | 54 | 0.080 |
Why?
|
Gene Dosage | 2 | 2011 | 1211 | 0.080 |
Why?
|
Time Factors | 10 | 2012 | 40154 | 0.080 |
Why?
|
Vascular Resistance | 2 | 2010 | 939 | 0.080 |
Why?
|
Vitamin B Complex | 1 | 2011 | 299 | 0.080 |
Why?
|
Urban Health | 3 | 2006 | 533 | 0.080 |
Why?
|
Wales | 3 | 2003 | 87 | 0.080 |
Why?
|
Carotid Arteries | 3 | 2010 | 934 | 0.080 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2008 | 49 | 0.080 |
Why?
|
Carotid Artery Diseases | 2 | 2005 | 872 | 0.080 |
Why?
|
Hemoglobins | 2 | 2012 | 1531 | 0.080 |
Why?
|
Vietnam | 1 | 2009 | 413 | 0.080 |
Why?
|
Environment | 3 | 2011 | 1120 | 0.080 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2012 | 792 | 0.080 |
Why?
|
Dietary Supplements | 4 | 2011 | 3446 | 0.070 |
Why?
|
Maternal Nutritional Physiological Phenomena | 2 | 2008 | 395 | 0.070 |
Why?
|
Regression Analysis | 8 | 2011 | 6331 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2011 | 10393 | 0.070 |
Why?
|
Censuses | 2 | 2008 | 198 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2009 | 370 | 0.070 |
Why?
|
Data Collection | 3 | 2008 | 3321 | 0.070 |
Why?
|
Chromosome Mapping | 3 | 2010 | 4616 | 0.070 |
Why?
|
Iron, Dietary | 1 | 2008 | 148 | 0.070 |
Why?
|
Caribbean Region | 1 | 2008 | 193 | 0.070 |
Why?
|
Gravidity | 1 | 2007 | 50 | 0.070 |
Why?
|
Carotid Artery, Common | 1 | 2008 | 172 | 0.070 |
Why?
|
Population Groups | 1 | 2008 | 209 | 0.070 |
Why?
|
Urbanization | 1 | 2008 | 100 | 0.070 |
Why?
|
Lipids | 4 | 2012 | 3322 | 0.070 |
Why?
|
Genetic Heterogeneity | 1 | 2010 | 735 | 0.070 |
Why?
|
Kallikreins | 1 | 2008 | 219 | 0.070 |
Why?
|
von Willebrand Factor | 1 | 2011 | 680 | 0.070 |
Why?
|
Republic of Belarus | 3 | 2011 | 38 | 0.070 |
Why?
|
Pakistan | 1 | 2008 | 299 | 0.070 |
Why?
|
Genetic Linkage | 2 | 2012 | 2342 | 0.070 |
Why?
|
Fingers | 1 | 2010 | 508 | 0.070 |
Why?
|
INDEL Mutation | 1 | 2008 | 266 | 0.070 |
Why?
|
Nicotinic Agonists | 1 | 2008 | 265 | 0.070 |
Why?
|
Universities | 2 | 2002 | 1004 | 0.070 |
Why?
|
Maternal Behavior | 1 | 2009 | 307 | 0.070 |
Why?
|
Parturition | 2 | 2010 | 454 | 0.070 |
Why?
|
Bone Density | 2 | 2010 | 3573 | 0.070 |
Why?
|
Homozygote | 2 | 2008 | 1774 | 0.070 |
Why?
|
Sweden | 2 | 2009 | 1382 | 0.070 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2008 | 325 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2008 | 11513 | 0.060 |
Why?
|
Mental Processes | 1 | 2007 | 242 | 0.060 |
Why?
|
Haplotypes | 3 | 2007 | 2722 | 0.060 |
Why?
|
Stomach Neoplasms | 3 | 2007 | 1481 | 0.060 |
Why?
|
Eczema | 1 | 2008 | 244 | 0.060 |
Why?
|
Sodium, Dietary | 2 | 2010 | 426 | 0.060 |
Why?
|
Social Facilitation | 1 | 2005 | 31 | 0.060 |
Why?
|
Puberty | 1 | 2009 | 501 | 0.060 |
Why?
|
Child Mortality | 1 | 2008 | 204 | 0.060 |
Why?
|
Infant Mortality | 2 | 2008 | 752 | 0.060 |
Why?
|
Lipoproteins | 2 | 2011 | 871 | 0.060 |
Why?
|
Pregnancy Complications | 3 | 2008 | 2971 | 0.060 |
Why?
|
Rural Population | 3 | 2011 | 2321 | 0.060 |
Why?
|
Psychology | 1 | 2007 | 353 | 0.060 |
Why?
|
Atherosclerosis | 4 | 2010 | 3418 | 0.060 |
Why?
|
Marriage | 1 | 2007 | 351 | 0.060 |
Why?
|
Forecasting | 2 | 2012 | 2936 | 0.060 |
Why?
|
Marijuana Smoking | 1 | 2008 | 261 | 0.060 |
Why?
|
Diabetes Mellitus | 6 | 2010 | 5886 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2011 | 15424 | 0.060 |
Why?
|
Sodium | 1 | 2010 | 1594 | 0.060 |
Why?
|
Metabolic Diseases | 1 | 2011 | 684 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2012 | 11923 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1011 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2008 | 606 | 0.060 |
Why?
|
Dehydration | 1 | 2006 | 216 | 0.060 |
Why?
|
Breast Neoplasms | 5 | 2007 | 21178 | 0.060 |
Why?
|
Aryldialkylphosphatase | 1 | 2004 | 64 | 0.060 |
Why?
|
Linkage Disequilibrium | 4 | 2011 | 1996 | 0.060 |
Why?
|
Dermatitis, Atopic | 1 | 2011 | 734 | 0.060 |
Why?
|
Dairy Products | 1 | 2007 | 490 | 0.060 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2008 | 372 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2010 | 1889 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6067 | 0.060 |
Why?
|
Cerebral Hemorrhage | 2 | 2008 | 2655 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2012 | 1997 | 0.060 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1119 | 0.060 |
Why?
|
Nicotine | 1 | 2008 | 680 | 0.050 |
Why?
|
Evidence-Based Medicine | 3 | 2011 | 3700 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2007 | 14672 | 0.050 |
Why?
|
London | 3 | 2010 | 233 | 0.050 |
Why?
|
Infant Formula | 1 | 2005 | 193 | 0.050 |
Why?
|
Multivariate Analysis | 5 | 2011 | 12069 | 0.050 |
Why?
|
Models, Statistical | 4 | 2011 | 5098 | 0.050 |
Why?
|
Leptin | 2 | 2012 | 1599 | 0.050 |
Why?
|
Life Expectancy | 1 | 2010 | 1248 | 0.050 |
Why?
|
Lung | 3 | 2011 | 10076 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 416 | 0.050 |
Why?
|
Cardiovascular System | 1 | 2010 | 839 | 0.050 |
Why?
|
Minisatellite Repeats | 1 | 2004 | 162 | 0.050 |
Why?
|
Eating | 2 | 2007 | 1541 | 0.050 |
Why?
|
Brain Ischemia | 2 | 2008 | 3001 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2008 | 649 | 0.050 |
Why?
|
Genetic Markers | 1 | 2009 | 2602 | 0.050 |
Why?
|
Bereavement | 1 | 2007 | 309 | 0.050 |
Why?
|
Disease | 1 | 2008 | 675 | 0.050 |
Why?
|
Selection, Genetic | 1 | 2007 | 877 | 0.050 |
Why?
|
Hair Removal | 1 | 2003 | 41 | 0.050 |
Why?
|
Death | 1 | 2007 | 685 | 0.050 |
Why?
|
Hyperlipoproteinemia Type II | 2 | 2005 | 396 | 0.050 |
Why?
|
Ethanol | 1 | 2008 | 1330 | 0.050 |
Why?
|
Heterozygote | 1 | 2009 | 2794 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2012 | 3227 | 0.050 |
Why?
|
Hearing Disorders | 1 | 2002 | 126 | 0.050 |
Why?
|
Vitamin B 6 | 1 | 2003 | 237 | 0.050 |
Why?
|
Siblings | 1 | 2006 | 828 | 0.050 |
Why?
|
Environmental Exposure | 3 | 2007 | 4546 | 0.050 |
Why?
|
Motor Activity | 3 | 2009 | 2713 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2174 | 0.050 |
Why?
|
Family Characteristics | 2 | 2006 | 1002 | 0.050 |
Why?
|
Diarrhea | 2 | 2006 | 1319 | 0.050 |
Why?
|
Health Status Indicators | 2 | 2004 | 969 | 0.050 |
Why?
|
Central Nervous System | 1 | 2008 | 1345 | 0.050 |
Why?
|
Drug Prescriptions | 1 | 2011 | 1664 | 0.050 |
Why?
|
Glutamine | 1 | 2004 | 575 | 0.050 |
Why?
|
Energy Intake | 1 | 2009 | 2145 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2010 | 1900 | 0.050 |
Why?
|
Receptors, Serotonin, 5-HT4 | 2 | 2011 | 15 | 0.050 |
Why?
|
Hyperinsulinism | 1 | 2004 | 402 | 0.050 |
Why?
|
Memory | 1 | 2011 | 2192 | 0.050 |
Why?
|
DNA-Binding Proteins | 4 | 2011 | 9612 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2004 | 533 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2008 | 1791 | 0.050 |
Why?
|
Aorta | 1 | 2008 | 2045 | 0.050 |
Why?
|
Osteoporosis | 1 | 2010 | 1604 | 0.040 |
Why?
|
Family | 3 | 2011 | 3210 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1055 | 0.040 |
Why?
|
Homeostasis | 2 | 2010 | 3345 | 0.040 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2002 | 362 | 0.040 |
Why?
|
Fathers | 3 | 2011 | 377 | 0.040 |
Why?
|
Arginine | 1 | 2004 | 931 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2010 | 2116 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2010 | 2196 | 0.040 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2008 | 1023 | 0.040 |
Why?
|
Anxiety Disorders | 1 | 2011 | 2745 | 0.040 |
Why?
|
Bone and Bones | 1 | 2010 | 2587 | 0.040 |
Why?
|
Comorbidity | 2 | 2012 | 10582 | 0.040 |
Why?
|
Hemodynamics | 1 | 2010 | 4186 | 0.040 |
Why?
|
International Cooperation | 1 | 2006 | 1434 | 0.040 |
Why?
|
Lung Neoplasms | 3 | 2011 | 13491 | 0.040 |
Why?
|
Prostatic Neoplasms | 3 | 2009 | 11097 | 0.040 |
Why?
|
Testicular Neoplasms | 1 | 2005 | 806 | 0.040 |
Why?
|
Liver Diseases | 1 | 2008 | 1304 | 0.040 |
Why?
|
Survival Rate | 2 | 2010 | 12823 | 0.040 |
Why?
|
Glutathione Transferase | 2 | 2011 | 565 | 0.040 |
Why?
|
Cognition | 3 | 2011 | 7059 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2010 | 20169 | 0.040 |
Why?
|
Uncertainty | 1 | 2003 | 765 | 0.040 |
Why?
|
Research Design | 2 | 2012 | 6210 | 0.040 |
Why?
|
Transcription Factors | 4 | 2011 | 12158 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4424 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2009 | 303 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2006 | 2972 | 0.040 |
Why?
|
DNA Copy Number Variations | 3 | 2011 | 2047 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 1009 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3599 | 0.030 |
Why?
|
Spirometry | 2 | 2011 | 928 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4114 | 0.030 |
Why?
|
Chronic Disease | 2 | 2009 | 9362 | 0.030 |
Why?
|
Colorectal Neoplasms | 3 | 2007 | 6966 | 0.030 |
Why?
|
Lung Diseases | 1 | 2006 | 1942 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 2 | 2010 | 539 | 0.030 |
Why?
|
Education | 2 | 2011 | 531 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5794 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3249 | 0.030 |
Why?
|
Health Promotion | 2 | 2010 | 2210 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 2010 | 1374 | 0.030 |
Why?
|
Chest Pain | 1 | 2002 | 1101 | 0.030 |
Why?
|
Microfilament Proteins | 2 | 2011 | 1130 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3724 | 0.030 |
Why?
|
Postmenopause | 1 | 2004 | 2518 | 0.030 |
Why?
|
Prognosis | 3 | 2011 | 29963 | 0.030 |
Why?
|
Adiponectin | 2 | 2012 | 1115 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2009 | 2930 | 0.030 |
Why?
|
Sex Characteristics | 3 | 2010 | 2647 | 0.030 |
Why?
|
Mutation | 3 | 2009 | 30211 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 2011 | 1418 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2002 | 1865 | 0.030 |
Why?
|
Cephalometry | 2 | 2007 | 380 | 0.030 |
Why?
|
Endpoint Determination | 2 | 2007 | 592 | 0.030 |
Why?
|
Air Pollution | 1 | 2007 | 2378 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9532 | 0.030 |
Why?
|
Population Surveillance | 3 | 2011 | 2594 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2009 | 81659 | 0.030 |
Why?
|
Nasal Bone | 1 | 2012 | 58 | 0.020 |
Why?
|
Asthma | 1 | 2011 | 6268 | 0.020 |
Why?
|
Liver | 1 | 2008 | 7578 | 0.020 |
Why?
|
Organ Size | 2 | 2009 | 2264 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2002 | 1465 | 0.020 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2011 | 127 | 0.020 |
Why?
|
Transcription Factor AP-2 | 1 | 2011 | 78 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2011 | 71 | 0.020 |
Why?
|
Glucose Transporter Type 2 | 1 | 2011 | 61 | 0.020 |
Why?
|
United States | 5 | 2011 | 72971 | 0.020 |
Why?
|
Cryptochromes | 1 | 2011 | 49 | 0.020 |
Why?
|
HMGA2 Protein | 1 | 2011 | 101 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5446 | 0.020 |
Why?
|
Dissent and Disputes | 1 | 2012 | 150 | 0.020 |
Why?
|
Tuberculosis | 1 | 2004 | 2011 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2003 | 3721 | 0.020 |
Why?
|
Carcinoma, Large Cell | 1 | 2011 | 114 | 0.020 |
Why?
|
Depression | 2 | 2008 | 8234 | 0.020 |
Why?
|
Nucleic Acid Denaturation | 1 | 2011 | 111 | 0.020 |
Why?
|
Interleukin-11 | 1 | 2010 | 59 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2003 | 1907 | 0.020 |
Why?
|
Base Pairing | 1 | 2011 | 139 | 0.020 |
Why?
|
Hospitals, Psychiatric | 1 | 2012 | 317 | 0.020 |
Why?
|
Emotions | 1 | 2002 | 2760 | 0.020 |
Why?
|
Maternal Exposure | 2 | 2009 | 1096 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 411 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2011 | 59548 | 0.020 |
Why?
|
Homeodomain Proteins | 2 | 2011 | 2429 | 0.020 |
Why?
|
Anxiety | 2 | 2003 | 4670 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2010 | 166 | 0.020 |
Why?
|
Economics | 1 | 2011 | 141 | 0.020 |
Why?
|
Gambia | 1 | 2010 | 104 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 386 | 0.020 |
Why?
|
Reference Values | 2 | 2008 | 4918 | 0.020 |
Why?
|
Soybean Oil | 1 | 2011 | 139 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2002 | 3561 | 0.020 |
Why?
|
Twin Studies as Topic | 1 | 2010 | 103 | 0.020 |
Why?
|
Thrombospondin 1 | 1 | 2011 | 257 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2012 | 411 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2011 | 286 | 0.020 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2009 | 19 | 0.020 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2009 | 28 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2012 | 353 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2002 | 3207 | 0.020 |
Why?
|
Nuclear Family | 1 | 2010 | 311 | 0.020 |
Why?
|
Apolipoproteins | 1 | 2012 | 328 | 0.020 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2009 | 34 | 0.020 |
Why?
|
Electrocardiography | 1 | 2002 | 6409 | 0.020 |
Why?
|
Thrombospondins | 1 | 2009 | 196 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2011 | 2392 | 0.020 |
Why?
|
tRNA Methyltransferases | 1 | 2009 | 50 | 0.020 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2009 | 90 | 0.020 |
Why?
|
Epidermis | 1 | 2011 | 539 | 0.020 |
Why?
|
Potassium Channels | 1 | 2011 | 534 | 0.020 |
Why?
|
Genitalia | 1 | 2009 | 114 | 0.020 |
Why?
|
Systole | 1 | 2011 | 935 | 0.020 |
Why?
|
Founder Effect | 1 | 2009 | 185 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 2011 | 381 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2010 | 344 | 0.020 |
Why?
|
Diastole | 1 | 2011 | 784 | 0.020 |
Why?
|
Vasomotor System | 1 | 2009 | 208 | 0.020 |
Why?
|
Brachial Artery | 1 | 2010 | 373 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2009 | 110 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2011 | 427 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2010 | 454 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2003 | 4054 | 0.020 |
Why?
|
France | 1 | 2009 | 496 | 0.020 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2008 | 247 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2011 | 740 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2009 | 507 | 0.020 |
Why?
|
Diet Records | 1 | 2009 | 425 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2009 | 432 | 0.020 |
Why?
|
Tympanic Membrane | 1 | 2009 | 232 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 2011 | 661 | 0.020 |
Why?
|
Queensland | 1 | 2006 | 53 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2012 | 903 | 0.020 |
Why?
|
Elasticity | 1 | 2008 | 654 | 0.020 |
Why?
|
Menstruation | 1 | 2008 | 310 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2827 | 0.020 |
Why?
|
Sample Size | 1 | 2009 | 845 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 935 | 0.020 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2011 | 454 | 0.020 |
Why?
|
Waist Circumference | 1 | 2010 | 935 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2008 | 526 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1150 | 0.020 |
Why?
|
Vasodilation | 1 | 2010 | 968 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2658 | 0.020 |
Why?
|
MEDLINE | 1 | 2006 | 119 | 0.020 |
Why?
|
Dietary Proteins | 1 | 2011 | 960 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2006 | 453 | 0.020 |
Why?
|
Hair | 1 | 2009 | 508 | 0.020 |
Why?
|
Human Genome Project | 1 | 2006 | 202 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2008 | 1479 | 0.020 |
Why?
|
Hearing | 1 | 2009 | 504 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2010 | 570 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1512 | 0.010 |
Why?
|
Tobacco Use Disorder | 1 | 2010 | 708 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2008 | 861 | 0.010 |
Why?
|
Weather | 1 | 2006 | 234 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2011 | 7868 | 0.010 |
Why?
|
Monitoring, Ambulatory | 1 | 2008 | 357 | 0.010 |
Why?
|
Codon | 1 | 2006 | 599 | 0.010 |
Why?
|
Motor Skills | 1 | 2007 | 521 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2009 | 12793 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1754 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2127 | 0.010 |
Why?
|
Spine | 1 | 2010 | 1139 | 0.010 |
Why?
|
Diabetic Angiopathies | 1 | 2008 | 806 | 0.010 |
Why?
|
Embryonic Development | 1 | 2008 | 722 | 0.010 |
Why?
|
Public Sector | 1 | 2005 | 266 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2010 | 872 | 0.010 |
Why?
|
Government Agencies | 1 | 2003 | 161 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1729 | 0.010 |
Why?
|
Child Rearing | 1 | 2003 | 74 | 0.010 |
Why?
|
Urocortins | 1 | 2002 | 20 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1758 | 0.010 |
Why?
|
Receptors, LDL | 1 | 2005 | 492 | 0.010 |
Why?
|
Exons | 1 | 2008 | 2391 | 0.010 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2004 | 271 | 0.010 |
Why?
|
Fibrin | 1 | 2005 | 514 | 0.010 |
Why?
|
Fruit | 1 | 2007 | 1165 | 0.010 |
Why?
|
Vegetables | 1 | 2007 | 1199 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2744 | 0.010 |
Why?
|
Hearing Loss | 1 | 2009 | 785 | 0.010 |
Why?
|
Patient Compliance | 1 | 2012 | 2697 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2007 | 1326 | 0.010 |
Why?
|
Animals | 3 | 2010 | 168965 | 0.010 |
Why?
|
Geography | 1 | 2004 | 651 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6215 | 0.010 |
Why?
|
Genes, BRCA1 | 1 | 2005 | 753 | 0.010 |
Why?
|
Trans-Activators | 1 | 2011 | 2856 | 0.010 |
Why?
|
Marital Status | 1 | 2003 | 426 | 0.010 |
Why?
|
National Health Programs | 1 | 2005 | 443 | 0.010 |
Why?
|
Alcoholism | 1 | 2012 | 1980 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2006 | 1716 | 0.010 |
Why?
|
Family Health | 1 | 2006 | 1254 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3344 | 0.010 |
Why?
|
Self-Assessment | 1 | 2003 | 400 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2800 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2516 | 0.010 |
Why?
|
Italy | 1 | 2003 | 856 | 0.010 |
Why?
|
Brain | 1 | 2007 | 27163 | 0.010 |
Why?
|
Mother-Child Relations | 1 | 2004 | 498 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2011 | 2979 | 0.010 |
Why?
|
Diet | 2 | 2010 | 8089 | 0.010 |
Why?
|
Iron | 1 | 2008 | 1811 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3618 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1794 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2002 | 1751 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5311 | 0.010 |
Why?
|
Sex Distribution | 1 | 2004 | 2276 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4052 | 0.010 |
Why?
|
Triglycerides | 1 | 2006 | 2444 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2887 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15567 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7121 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2002 | 1253 | 0.010 |
Why?
|
Computational Biology | 1 | 2009 | 3567 | 0.010 |
Why?
|
Glucose | 1 | 2009 | 4341 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7446 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2005 | 1388 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3440 | 0.010 |
Why?
|
Cochlea | 1 | 2002 | 848 | 0.010 |
Why?
|
Pedigree | 1 | 2003 | 4539 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 4049 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9464 | 0.010 |
Why?
|
Placenta | 1 | 2005 | 1726 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2012 | 4422 | 0.010 |
Why?
|
Pre-Eclampsia | 1 | 2005 | 1255 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2002 | 1407 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 4813 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11657 | 0.010 |
Why?
|
DNA | 1 | 2008 | 7210 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6360 | 0.010 |
Why?
|
Schizophrenia | 1 | 2012 | 6977 | 0.010 |
Why?
|
MicroRNAs | 1 | 2009 | 3792 | 0.010 |
Why?
|
Hemorrhage | 1 | 2005 | 3464 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 8068 | 0.010 |
Why?
|
Mental Health | 1 | 2003 | 3272 | 0.000 |
Why?
|
Algorithms | 1 | 2008 | 14098 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 2004 | 5519 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 65295 | 0.000 |
Why?
|
Inflammation | 1 | 2005 | 10869 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 22361 | 0.000 |
Why?
|
Mice | 1 | 2002 | 81912 | 0.000 |
Why?
|